[Chine] Chinese execs took firm’s Covid-19 vaccine pre-trials ‘to lead by example’
Auteur : Zhuang Pinghui, journalistes du journal South China Morning Post à Pékin
Production : South China Morning Post, quotidien de langue anglaise publié à Hong Kong depuis 1903. Sa diffusion s’élève à 104 000 exemplaires. Il est publié par le groupe SCMP, propriété de du groupe Alibaba depuis 2015.
Diffusion : site du journal South China Morning Post
Date et Heure : 7 octobre 2020, 09:00
– China National Biotec Group tried its experimental vaccines on 180 executives before human trials were approved
– ‘My arm went blue from drawing blood dozens of times,’ the company’s vice-president Zhang Yuntao says
Source : Zhuang Pinghui, “Chinese execs took firm’s Covid-19 vaccine pre-trials ‘to lead by example’”, South China Morning Post, 07/10/2020. URL : https://www.scmp.com/news/china/society/article/3104364/my-arm-went-blue-chinese-execs-tested-covid-19-vaccine-lead (consulté le 07/10/2020).
Photo “à la une” : One CNBG executive said taking his company’s vaccines produced antibody levels higher than those of recovered Covid-19 patients. © EPA-EFE
OpenEdition vous propose de citer ce billet de la manière suivante :
Admin IAO (7 octobre 2020). [Chine] Chinese execs took firm’s Covid-19 vaccine pre-trials ‘to lead by example’. Asie Orientale et Coronavirus. Consulté le 10 octobre 2024 à l’adresse https://doi.org/10.58079/n7oy
